DE60111538D1 - Therapeutische verbindungen gegen eierstockkrebs - Google Patents

Therapeutische verbindungen gegen eierstockkrebs

Info

Publication number
DE60111538D1
DE60111538D1 DE60111538T DE60111538T DE60111538D1 DE 60111538 D1 DE60111538 D1 DE 60111538D1 DE 60111538 T DE60111538 T DE 60111538T DE 60111538 T DE60111538 T DE 60111538T DE 60111538 D1 DE60111538 D1 DE 60111538D1
Authority
DE
Germany
Prior art keywords
therapeutic compounds
compounds against
compounds
against egg
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60111538T
Other languages
English (en)
Inventor
A Nicolette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of DE60111538D1 publication Critical patent/DE60111538D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60111538T 2000-08-17 2001-08-17 Therapeutische verbindungen gegen eierstockkrebs Expired - Lifetime DE60111538D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22624300P 2000-08-17 2000-08-17
PCT/US2001/025708 WO2002014352A2 (en) 2000-08-17 2001-08-17 Therapeutic compounds for ovarian cancer

Publications (1)

Publication Number Publication Date
DE60111538D1 true DE60111538D1 (de) 2005-07-21

Family

ID=22848127

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60111538T Expired - Lifetime DE60111538D1 (de) 2000-08-17 2001-08-17 Therapeutische verbindungen gegen eierstockkrebs

Country Status (8)

Country Link
US (1) US20020160959A1 (de)
EP (1) EP1309625B1 (de)
JP (1) JP2004506421A (de)
AT (1) ATE297949T1 (de)
AU (1) AU2001283416A1 (de)
CA (1) CA2417152A1 (de)
DE (1) DE60111538D1 (de)
WO (1) WO2002014352A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901256D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Novel compounds

Also Published As

Publication number Publication date
WO2002014352A3 (en) 2003-01-16
WO2002014352A9 (en) 2004-03-04
WO2002014352A2 (en) 2002-02-21
JP2004506421A (ja) 2004-03-04
ATE297949T1 (de) 2005-07-15
EP1309625B1 (de) 2005-06-15
AU2001283416A1 (en) 2002-02-25
CA2417152A1 (en) 2002-02-21
EP1309625A2 (de) 2003-05-14
US20020160959A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
PH12019502484A1 (en) Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereof
IL214325A (en) Antibody against cmet, a drug that includes and uses it
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
ATE513563T1 (de) Therapeutische und toleranz-induzierende antikörper
WO2004064759A3 (en) Use of tryptanthrin compounds for immune potentiation
UA118332C2 (uk) Білок, що зв'язує антиген cd27l
EA201270625A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
TR200103018T2 (tr) İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
CR11399A (es) ANTICUERPOS ANTI-IL-12/23p40, EPITOPES, FORMULACIONES, COMPOSICIONES, METODOS Y USOS
ATE497392T1 (de) Therapie mit anti-cd4-antikörpern und bestrahlung
DE60109922D1 (de) Therapeutische verbindungen gegen eierstockkrebs
WO2008034074A3 (en) Cyclosphosphamide in combination with anti-idiotypic vaccines
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
ATE418344T1 (de) Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
ATE313560T1 (de) Therapeutische anti-cytomegalovirus verbindungen
WO2001068677A3 (en) Derivatives of breast canacer antigen her-2 for therapeutical use
ATE525401T1 (de) Vom tumorantigen 5t4 abgeleitete mhc-klasse-i- und ii-peptidantigene
DE60111538D1 (de) Therapeutische verbindungen gegen eierstockkrebs
WO2002012272A8 (en) Therapeutic anti-melanoma compounds
WO2001070767A3 (en) Therapeutic anti-melanoma compounds
WO2001092307A3 (en) Therapeutic compounds for ovarian cancer
WO2003037264A3 (en) Therapeutic anti-hiv (vpr) compounds
WO2001092294A3 (en) Therapeutic anti-melanoma compounds

Legal Events

Date Code Title Description
8332 No legal effect for de